Connect your AI

AptarGroup ATR Shares (Diluted)

Shares (Diluted) at other companies

West Pharmaceutical ServicesWST

72.4M-0.8%

NordsonNDSN

56.1M-1.6%

Baxter InternationalBAX

515M+0.2%

Halozyme TherapeuticsHALO

122.9M-3.0%

BrightSpring Health Services, Inc.BTSG

221.3M+3.0%

United TherapeuticsUTHR

47.2M-2.9%

Other financials

Income statement

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AptarGroup's shares (diluted)?: AptarGroup (ATR) reported shares (diluted) of 64.8M in Q1 2026.
How has AptarGroup's shares (diluted) changed year-over-year?: AptarGroup's shares (diluted) decreased by 3.9% year-over-year, from 67.5M to 64.8M.